ZalVac
Zalvac AB is founded around the research of Birgitta Henriques Normark and Staffan Normark. Their research explores the role of membrane vesicles – small nanosized particles released by bacteria – in the immune response. ZalVac aims to create effective vaccines that can induce robust immunity against various strains of bacteria.